In short
Perimenopause is the hormonal transition period preceding menopause, typically beginning in the mid-40s but sometimes earlier, characterised by fluctuating and eventually declining oestrogen and progesterone levels, irregular cycles, and a range of symptoms driven by hormonal variability. At CLCC, care for perimenopause follows a five-step structured assessment: Assess, Identify, Reduce, Restore, Continue, addressing the systemic contributors alongside standard medical treatment, rather than symptom management alone.
About This Condition
Perimenopause is a hormonal transition, its severity is determined by the systemic environment it occurs in.
Perimenopause is the hormonal transition period preceding menopause, typically beginning in the mid-40s but sometimes earlier, characterised by fluctuating and eventually declining oestrogen and progesterone levels, irregular cycles, and a range of symptoms driven by hormonal variability. The transition typically lasts 4–8 years before the final menstrual period defines menopause.
The severity of perimenopausal symptoms varies considerably between women, and the variation is not random. The metabolic environment determines how severely the hormonal fluctuation impacts the body. Women with established insulin resistance experience more significant weight gain, mood disruption, and hot flash severity during the transition. Women with adequate nutritional status, vitamin D, magnesium, B vitamins, experience less severe bone loss and mood disruption. Women with good gut health experience more efficient oestrogen clearance, reducing the impact of oestrogen fluctuation. CLCC builds a perimenopausal care plan that supports the systemic environment through the transition, reducing symptom severity, protecting metabolic health, and preserving bone density.
Symptoms
Common symptoms and presentations.
Irregular menstrual cycles, shorter, longer, heavier, lighter, or unpredictable
Hot flashes, sudden waves of heat, flushing, and sweating
Night sweats disrupting sleep
Sleep difficulty, onset or maintenance insomnia
Mood changes, irritability, low mood, or anxiety that was not previously present
Brain fog and cognitive slowing
Vaginal dryness and changes in sexual comfort
Accelerating weight gain, particularly central
Joint aching that was not previously present
Contributing Factors
What drives and sustains this condition.
Oestrogen fluctuation and decline
Perimenopausal oestrogen fluctuation drives hot flashes, mood changes, sleep disruption, and vaginal symptoms. The severity of these symptoms is modulated by the systemic inflammatory environment, metabolic health, and nutritional status.
Metabolic acceleration
Declining oestrogen worsens insulin resistance, accelerates central fat deposition, and elevates cardiovascular risk markers, making perimenopause a period of significant metabolic acceleration that requires proactive management.
Bone density acceleration
Oestrogen decline dramatically accelerates bone resorption. Perimenopausal bone loss can reach 2–3% per year, the most rapid bone loss period in a woman's life. Nutritional correction and weight-bearing activity during perimenopause are the most critical bone health interventions available.
Sleep architecture disruption
Hot flashes and progesterone decline disrupt deep sleep architecture, reducing the restorative sleep that maintains cognitive function, mood, immune health, and metabolic regulation. Sleep disruption compounds every other perimenopausal symptom.
The CLCC Method: All Five Steps
Assessment first. Then all five steps, applied specifically.
Full hormonal, metabolic, bone health, and nutritional assessment
Hormonal profile, FSH, LH, oestradiol, progesterone, at appropriate cycle timing. Fasting insulin, HbA1c, and lipid profile for metabolic assessment. Vitamin D, calcium, magnesium, and K2 for bone health. B vitamins and magnesium for symptom support. DEXA scan review where indicated. Sleep quality and symptom severity scored.
Identify which dimensions of perimenopause are most active and addressable
Metabolic acceleration, bone loss rate, sleep disruption, and hot flash severity each require different primary intervention emphasis. The assessment identifies the dominant burden to prioritise care plan structure.
Coordinated metabolic, bone, nutritional, and symptom support
Low-insulin dietary protocol for metabolic protection. Vitamin D3, calcium, magnesium, and K2 for bone preservation. Phytoestrogen-rich dietary protocol for symptom support where appropriate. Weight-bearing exercise structure. Sleep restoration programme. Stress load reduction.
Track metabolic markers, bone health, and symptom severity at 6-month intervals
Metabolic panel, bone density markers, and hormonal profile reviewed at 6-month intervals through the transition. Hot flash frequency and severity tracked monthly. Sleep quality and mood assessed. Protocol adjusted as the transition progresses.
Sustain metabolic and bone health through and beyond the transition
Perimenopausal interventions must transition into post-menopausal maintenance. The Continue phase ensures metabolic, bone, and nutritional management continues without interruption through the hormonal transition, preventing the accelerated deterioration that occurs when the transition is unmanaged.
FAQs
Common questions about care.
Is HRT necessary during perimenopause?+
HRT is an appropriate and effective option for many perimenopausal women, particularly for severe vasomotor symptoms, significant sleep disruption, or rapidly declining bone density. CLCC care addresses the systemic dimensions of perimenopause that HRT does not: metabolic protection, gut health, nutritional optimisation, and bone nutrition. The two approaches are complementary, not mutually exclusive.
How early can perimenopausal changes begin?+
Perimenopausal hormonal changes can begin as early as the late 30s in some women, years before symptoms are recognised as perimenopause. Irregular cycles, worsening PMS, weight gain without dietary change, and new-onset sleep disruption in the 40s are often the earliest signs. Early recognition and intervention produces better metabolic and bone outcomes than late intervention.